BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18697482)

  • 1. [Gelatin particle agglutination (PA) antibody: comparison to neutralizing antibody (NT) and hemagglutination inhibition (HI) antibody and relationship to IgG avidity].
    Saika S; Matsunaga T; Ogawa T; Ichinohe S
    Kansenshogaku Zasshi; 2008 Jul; 82(4):310-6. PubMed ID: 18697482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measles antibody followed after measles vaccination: comparison with gelatin beads agglutination (PA) antibody, hemagglutination inhibition (HI) antibody and IgG-avidity].
    Saika S; Suzuki K; Ichinohe S
    Kansenshogaku Zasshi; 2003 Oct; 77(10):809-14. PubMed ID: 14608913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between measles-neutralizing antibody and HI antibody, between measles-neutralizing antibody and PA antibody among pregnant women, and protective levels of three titration types].
    Takayama N; Shoda A; Okazaki T; Ichinohe S; Saika S; Inaba N
    Kansenshogaku Zasshi; 2007 Nov; 81(6):675-80. PubMed ID: 18095465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EIA-IgG antibody measles prevention level estimated from measles neutralizing, particle agglutination and hemagglutination-inhibition antibody titer].
    Takayama N; Saika S; Ichinohe S
    Kansenshogaku Zasshi; 2009 Sep; 83(5):519-24. PubMed ID: 19860253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of immunity to measles virus in young adults: comparative evaluation of a commercial enzyme immunoassay and the hemagglutination inhibition techniques.
    Duvdevani P; Varsano N; Slepon R; Lerman Y; Shohat T; Mendelson E
    Clin Diagn Virol; 1996 Oct; 7(1):1-6. PubMed ID: 9077425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of antibodies against measles antigen in institutionalized patients with severe motor and intellectual disability].
    Machida Y; Yamamoto J; Yano Y; Yano T
    Kansenshogaku Zasshi; 2008 Jul; 82(4):328-34. PubMed ID: 18697485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive hemagglutination test for measles immunity and serodiagnosis.
    Sakata H; Sugiura A
    J Clin Microbiol; 1988 Apr; 26(4):636-40. PubMed ID: 3130389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gelatin particle agglutination and hemagglutination inhibition tests for measles seroepidemiology studies.
    Miyamura K; Sato TA; Sakae K; Kato N; Ogino T; Yashima T; Sasagawa A; Chikahira M; Itagaki A; Katsuki K; Matsunaga Y; Utagawa E; Takeda N; Inouye S; Yamazaki S
    Arch Virol; 1997; 142(10):1963-70. PubMed ID: 9413505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a new neutralization test for measles virus.
    Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
    J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the immunization effect of measles vaccine by capture-EIA].
    Fang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):297-9. PubMed ID: 1300252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines.
    de Souza VA; Pannuti CS; Sumita LM; de Andrade JĂșnior HF
    J Med Virol; 1997 Jul; 52(3):275-9. PubMed ID: 9210036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term antibody response after measles vaccination in an isolated arctic society in Greenland.
    Pedersen IR; Mordhorst CH; Ewald T; von Magnus H
    Vaccine; 1986 Sep; 4(3):173-8. PubMed ID: 3532604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection.
    Narita M; Yamada S; Matsuzono Y; Itakura O; Togashi T; Kikuta H
    Clin Diagn Lab Immunol; 1996 Mar; 3(2):211-5. PubMed ID: 8991638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simplified immunoassay based on measles virus recombinant hemagglutinin protein for testing the immune status of vaccinees.
    Bouche F; Ammerlaan W; Fournier P; Schneider F; Muller CP
    J Virol Methods; 1998 Sep; 74(1):77-87. PubMed ID: 9763131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles virus specific antibody in infants in a highly vaccinated society.
    Chui LW; Marusyk RG; Pabst HF
    J Med Virol; 1991 Mar; 33(3):199-204. PubMed ID: 1880496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.
    Bouche F; Ammerlaan W; Berthet F; Houard S; Schneider F; Muller CP
    J Clin Microbiol; 1998 Mar; 36(3):721-6. PubMed ID: 9508302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of eastern equine encephalomyelitis virus infection in horses by immunoglobulin M and G capture enzyme-linked immunosorbent assay.
    Sahu SP; Alstad AD; Pedersen DD; Pearson JE
    J Vet Diagn Invest; 1994 Jan; 6(1):34-8. PubMed ID: 8011779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection.
    Nair N; Moss WJ; Scott S; Mugala N; Ndhlovu ZM; Lilo K; Ryon JJ; Monze M; Quinn TC; Cousens S; Cutts F; Griffin DE
    J Infect Dis; 2009 Oct; 200(7):1031-8. PubMed ID: 19702505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases.
    Sowers SB; Rota JS; Hickman CJ; Mercader S; Redd S; McNall RJ; Williams N; McGrew M; Walls ML; Rota PA; Bellini WJ
    Clin Vaccine Immunol; 2016 Aug; 23(8):707-16. PubMed ID: 27335386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.